Impact of relative dose intensity of R-CCOP regimen in elderly patients with diffuse large B-cell lymphoma in China

Impact of relative dose intensity of R-CCOP regimen in elderly patients with diffuse large B-cell lymphoma in China

Background: The actual relative dose intensity (RDI) of the attenuated R-CCOP regimen (rituximab, cytoxan, pegylated liposomal doxorubicin [PLD], vincristine, and prednisone) has not been fully investigated in Chinese geriatric patients with diffuse large B-cell lymphoma (DLBCL). In particular, the...

Full description

Bibliographic Details
Main Authors: Hongye Gao, Yanfei Liu, Yanfeng Xu, Lan Mi, Chen Zhang, Xiaopei Wang, Yuqin Song, Jun Zhu, Weiping Liu
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of the Formosan Medical Association
Subjects:
Lymphoma
Large B Cell
Diffuse
Aged
Administration and dosage
Survival
Online Access:http://www.sciencedirect.com/science/article/pii/S092966462200242X

Internet

http://www.sciencedirect.com/science/article/pii/S092966462200242X

Similar Items